Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle...
3 insider purchases on record · latest filing 2025-11-20.
Insiders have also filed 1 sale transaction at PLUR.